Bedfont® opens a new wellness space for encouraging a carbon conscious approach and memorialising loved ones

Bedfont® proudly announces the successful transformation of unused space into a Wellbeing Garden. This innovative initiative not only underlines Bedfont’s commitment to its employees’ wellness but also champions environmental conservation through biodiversity efforts. The garden, crafted using 90% reclaimed materials, serves as a touching memorial to lost loved ones.

Bedfont® encourages a healthy work-life balance and the Wellbeing Garden is a testament to this ethos, designed to provide employees with a serene and revitalising space to destress, recharge, and connect with nature. The garden’s carefully curated landscape also serves as a natural habitat for local flora and fauna, contributing to the preservation of local ecosystems, thanks to its variety of flowers and vegetables, and it even has a dedicated Bat box.

Managing Director, Jason Smith, remarks, “The Wellbeing Garden holds deep sentimental value as a memorial to lost loved ones, Niki and Pat. This garden was Niki’s dream and now it is a reality, underpinning the work she did promoting wellbeing for the Bedfont® Family. Pat, a beloved member of the Bedfont® Family and keen gardener, donated a lot of the greenery which now homes multiple ecosystems. Through this garden, not only does their memory live on, but it allows us to work towards our core value of being more Carbon Conscious, whilst providing a beautiful space for the Bedfont Family to promote wellbeing.”

Bedfont® extends its gratitude to the grant providers, Beyond Procurement, whose support made this visionary project a reality. The company remains steadfast in its commitment to nurturing a culture that prioritises employee welfare and environmental responsibility.

Bedfont® Scientific Ltd. helps fundraising reach £1000 for Cancer Research UK

Local Med-tech company, Bedfont® Scientific Ltd., is proudly donating £200 to support the noble fundraising efforts of its employees, the Bedfont® Family, who ran the Pretty Muddy 5K Obstacle Course on Saturday 1st July 2023, for Cancer Research UK. So far, the team have raised an inspiring £800 towards cancer research initiatives, meaning with Bedfont’s Donation the fundraising will reach an impressive £1000.

According to WHO, nearly every family globally is affected by cancer; 1 in 5 people are diagnosed with cancer during their lifetime, and the diagnosis affects the health and well-being of all those involved, including family members and caregivers1.

Jason Smith, Managing Director at Bedfont®, explained, “Our Bedfont® Family has very recently been affected by cancer and it has been a really difficult year for so many of us. I am inspired by the willpower of the Pretty Muddy runners, and wish to also contribute to a cause close to all of our hearts.”

The funds raised through this run will be directed to Cancer Research UK, to help groundbreaking cancer research and patient support. To donate, please visit: https://www.cancerresearchuk.org/get-involved/donate

References:

  1. Amplifying the lived experience of people affected by cancer [Internet]. World Health Organization; [cited 2023 Jul 3]. Available from: https://www.who.int/activities/amplifying-the-lived-experience-of-people-affected-by-cancer

Med-tech manufacturer, Bedfont® Scientific Ltd., launches new CELLER8® PEMF device with exclusive distributor, NewMed Ltd. at the Health Optimisation Summit 2023

Bedfont®, a leading innovator in medical devices with over 40 years of manufacturing experience, proudly announces the launch of a new PEMF (Pulsed Electromagnetic Field) device, CELLER8®. With NewMed Ltd. as the global exclusive distributor, the CELLER8® was introduced at the Health Optimisation Summit 2023.

CELLER8® harnesses the power of Pulsed Electromagnetic Field therapy, using the earth’s natural magnetic waves to concentrate and send electromagnetic pulses to specific areas of the body. The underlying principle of PEMF therapy is that it aims to restore balance by supporting healthy cellular function, promoting circulatory wellness, and supporting overall health and wellness.

Jason Smith, Managing Director at Bedfont®, comments, “With over 40 years of manufacturing experience from Bedfont®, and NewMed’s PEMF knowledge, we’ve combined our joint expertise and passion for driving innovation to develop a PEMF device with the user in mind. This summit is the ideal location to launch CELLER8® as the summit focuses on everything in the general health, wellbeing, nutrition, biohacking and fitness worlds.”

Andy Smith, Managing Director at NewMed, adds, “Having benefited from PEMF therapy myself, I founded NewMed to help others learn about and experience this life changing technology. I’m proud to say we’re the one-stop-shop for PEMF devices, and we’re excited to be launching the CELLER8® – it’s compact, sleek, and powerful – perfect for individuals seeking natural, non-invasive, solutions to enhance their overall health and well-being.”

The CELLER8® was launched at the Health Optimisation Summit, which took place 17th – 18th June, at the Business Design Centre, London. Visit http://www.celler8.com for more information.

Med-tech company, Bedfont®, has received the highest accolade for their workplace initiatives

In just under 6 months, Kent County Council has presented Bedfont® with the highest award possible for promoting a positive work environment, a healthy work/life balance, and showing its commitment to reducing its carbon footprint.

After joining the Healthy Workplace Programme last year, in October Bedfont® announced it had received 3 awards for their efforts to create a positive workplace environment. Now in just under 6 months, Bedfont® has excelled in building new initiatives and putting the wellbeing of employees at the forefront of the business, resulting in being rewarded with the Platinum status.

The programme, funded by the KCC and Medway Council, helps to support health and wellbeing at work with relevant policies, training and guidance(1). Recent studies have shown that those with a healthy work/life balance have more motivation and are more productive at work(2).

Jason Smith, Managing Director at Bedfont®, remarks, “I’m over the moon with having achieved the Platinum award in just under 6 months! It’s really great to be recognised for the efforts we are making to make Bedfont® a great and innovative place to work. Although this might be the highest achievement, there is always more we can do to improve; I look forward to the Bedfont® Family rising to the next challenge as we continue to grow.”

The Kent and Medway awards team, comments, “This award is the highest level of achievement within the programme and highlights Bedfont® Scientific’s commitment as a responsible business in the local community. Although it can be difficult to suggest improvements and progression for a business that works at the Platinum level, Bedfont® should be very proud of their work around health and wellbeing as they have implemented many great initiatives and ensure to maintain their current culture.”

References:

1. Council M. Healthy workplace programme [Internet]. Healthy Workplace Programme | Medway Council. [cited 2023Mar16]. Available from: https://www.medway.gov.uk/healthyworkplace

2. 10 statistics on work-life balance that May surprise you (2023) [Internet]. Apollo Technical LLC. 2023 [cited 2023Mar16]. Available from: https://www.apollotechnical.com/statistics-on-work-life-balance/

Local med-tech company, Bedfont® Scientific Ltd., is recognised for its Innovation for the 2ndyear in a row at the Kent Invicta Chamber of Commerce (KICC) Awards

On Thursday 17th November 2022, Kent’s esteemed businesses gathered at Westenhanger Castle for the annual Kent Invicta Chamber of Commerce (KICC) Awards to celebrate the achievements of Kent companies. Bedfont is delighted to share that it has been named as Innovative Business of the Year, for the 2nd year running.

Bedfont, who design and manufacture breath analysis medical devices, have been trading since 1976, and export their products across the globe thanks to their network of carefully selected distributors.

Amidst the challenges posed by COVID, Bedfont® used its innovative nature to adapt its products and services to successfully navigate the pandemic, and as a result has come out the other side stronger, now offering remote breath testing devices.

Jason Smith, Managing Director at Bedfont, explains, “We created webinars and marketing materials to educate our customers on how they could safely continue breath testing. This led to a Healthcare Professional contacting us, asking for a way to help them continue CO monitoring for smoking cessation remotely. The iCOquit® was designed as a personal CO monitor, however we adapted this and the accompanying app and literature to enable the iCOquit® to be used for remote CO testing. This was so successful, the market then asked for a version to help expectant mothers quit smoking, and we provided –these innovative moves helped us succeed during a time of economic regression The Bedfont Family worked so hard to make this happen and I couldn’t be prouder to share this Innovation award with them.”

Kent Family Business, Bedfont® Scientific Ltd., have been awarded Bronze, Silver, and Gold Kent and Medway Healthy Workplace Awards.

In 2022, Bedfont® joined the Healthy Workplace Programme, which involves building new initiatives and putting the wellbeing of employees at the forefront of the business. Bedfont is pleased to announce it has received 3 awards for their efforts to create a positive workplace environment.

The programme funded by the KCC and Medway Council, helps to support health and wellbeing at work with relevant policies, training and guidance(1). Recent studies have shown that those with a healthy work/life balance have more motivation and are more productive at work(2).

Jason Smith, Managing Director at Bedfont®, comments, “As a second-generation family business, Bedfont® has implemented workplace policies that focus on creating a friendly and positive workplace atmosphere with the Bedfont Family at its heart. We have been working hard to achieve a healthy work/life balance for our employees for some time now, and it’s really rewarding for us as an employer to know this has been recognised with the Healthy Workplace Awards. We look forward to continuing and improving upon these efforts, and we have our sights set on the Platinum award next.”

The Kent and Medway awards team, comments, “From the great evidence submitted and interviews conducted, it is evident Bedfont Scientific has created a very social and inclusive organisation which always looks at ways to introduce new initiatives and equally cares for the wellbeing of its customers as much as its staff. Well done to you and all your hard work in making Bedfont Scientific a lovely place to work”

References:

  1. Council M. Kent and Medway Healthy Workplace Programme | Medway Council [Internet]. Medway.gov.uk. 2022 [cited 6 October 2022]. Available from: https://www.medway.gov.uk/healthyworkplace
  2. 10 Statistics on Work-Life Balance That May Surprise You (2022) [Internet]. Apollo Technical LLC. 2022 [cited 23 September 2022]. Available from: https://www.apollotechnical.com/statistics-on-work-life-balance/

Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA

UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation.

The NObreath®, which conforms to ATS and ERS guidelines1, is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) in human breath. The production of nitric oxide is often found to be increased in inflammatory conditions such as asthma.

The NObreath® works by measuring FeNO through breath analysis, making the process quick, simple, and non-invasive for both the Healthcare Professional and the patient. Interpreting FeNO levels aids in identifying patients who do/do not require ongoing treatment2 whilst also differentiating between allergic (eosinophilic) and non-allergic asthma3, and if used daily, FeNO measurements can help to predict and prevent exacerbations and attacks4.

Jason Smith, Managing Director at Bedfont, comments, “NObreath has been available outside the US for over 12 years now, we have been working towards FDA clearance for quite some time and we are over the moon to have received it. We are one step closer to achieving our purpose; to make FeNO monitoring lower cost and therefore more accessible globally. According to the Centre for Disease Control (CDC), around 25 million Americans suffer from asthma; that’s a potential 25 million people that the NObreath® can help through FeNO monitoring.”

-ends-

REFERENCES

  1. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005; American Journal of Respiratory and Critical Care Medicine; vol. 171: 912-930;2005
  2. Andrew D. Smith, Jan O. Cowan, Sue Filsell, Chris MacLachlan, Gabrielle Monti-Sheehan, Pamela Jackson and D. Robin Taylor. Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests. Am J Respir Crit Care Med Vol 169. pp 473-478, 2004.
  3. Coumou HBel E. Improving the diagnosis of eosinophilic asthma [Internet]. Taylor and Francis online. 2017 [cited 21 December 2021]. Available from: http://www.tandfonline.com/doi/full/10.1080/17476348.2017.1236688
  4. Harkins M. Exhaled Nitric Oxide Predicts Asthma Exacerbation [Internet]. Taylor & Francis. 2017 [cited 21 December 2021]. Available from: http://www.tandfonline.com/doi/abs/10.1081/JAS-120033990

Bedfont and its sponsored football team, Medway United FC, have teamed up to donate 125 gifts to Medway hospital and 125 gifts to Children’s Cancer Charity, My Shining Star

Medical device manufacturer, Bedfont Scientific Ltd., has joined forces with the local football team it sponsors, Medway United FC, to spread a little Christmas Joy by donating 250 gifts. On Tuesday 14th December, Bedfont and Medway United donated 125 gifts to Medway Hospital for the children who will be there over Christmas, and another 125 gifts to the children’s cancer charity ‘My Shining Star’ also based in Medway.

Jason Smith, Managing Director at Bedfont, “Winston Churchill said, ‘We make a living by what we get. We make a life by what we give.’ Medway United and Bedfont are happy to spread some festive cheer at a time of year, which can be so difficult for many.”

Cherly Jones, Fundraising Officer at the Medway Hospital Charity, “We are extremely grateful to Bedfont and Medway United for their incredible donation of presents to our children’s ward at Medway Hospital.  Their gEnerosity is very much appreciated, especially at this time of year, and I know our patients will be thrilled to receive them.”

Local medical device manufacturer, Bedfont Scientific Ltd., returns to the era it all began for its 45th birthday

On 8th December, Kent Med-tech company, Bedfont Scientific Ltd. celebrated 45 years of business with a 1970’s themed party. The Bedfont Family celebrated with costumes from prominent 70’s characters, 70’s party games, 70’s party food, and a video tribute from a number of employees and distributors who have contributed to the business since 1976.

Jason Smith, Managing Director, remarks, “Back in 1976 the incidence of serious hazards related to medical gas supply systems was described as ‘alarming’. My favourite inspirational quote is ‘a pessimist sees the difficulty in every opportunity, an optimist sees the opportunity in every difficulty’ from Winston Churchill. I think this describes very aptly how my godfather, John Marron, went on to design and manufacture Bedfont’s first ever product; the TM3 Medi-Gas Check for ensuring gas supply systems were safe before use. This product undoubtedly saved lives and started Bedfont on a road of life-saving gas monitors. Back then, Bedfont employed one person and was based in a bedsit in London; now we employ 50 direct staff, have over 80 global distributors, and even have our own offices in Kent and Austria. We will continue to innovate new non-invasive breath analysis devices to bring these life-saving products into people’s homes worldwide, and hope to do so for the next 45 years!”

The KICC awards recognises Med-tech company, Bedfont’s innovative success

The long-awaited Kent Invicta Chamber of Commerce (KICC) awards took place on Thursday 18th November, and named medical device manufacturer, Bedfont, as Innovative Business of the Year.

The KICC awards, celebrated every year, brings together businesses across Kent, showcasing their amazing achievements. The awards had unfortunately been delayed due to COVID-19, but finally took place on Thursday at Westhanger Castle, Hythe, boasting an even more impressive evening than ever before.

Local medical technology business, Bedfont, was delighted to have received the accolade for Innovative business of the year. A multi-award winning medical device manufacturer, Bedfont is based in Harrietsham, Kent. Their products help to detect a range of medical conditions via breath analysis, removing the need for needles, blood samples, and long waiting time for results.

Managing Director, Jason Smith, explained, “It’s been a difficult couple of years, being a breath analysis device manufacturer during the Coronavirus pandemic – a disease spread by breath! However, Bedfont did what it does best; innovate. We adapted our products, resources, and services to better support both our employees and customers remotely and the Bedfont Family are over the moon to see that this has been recognised.”

Back to top